| 标题 |
A multicenter randomized phase II trial of erlotinib with and without hydroxychloroquine (HCQ) in TKI-naive patients (pts) with epidermal growth factor receptor (EGFR) mutant advanced non-small cell lung cancer (NSCLC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Joel W. Neal; Heather A. Wakelee; Josephine Louella Feliciano; Sarah B. Goldberg; Daniel Morgensztern; et al 出版日期:2019-01-04 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)